Lumos Diagnostics Holdings Ltd

LDX

Company Profile

  • Business description

    Lumos Diagnostics Holdings Ltd is engaged in selling Products and providing Services to customers. Its product offering includes rapid, point-of-care diagnostic test products, mainly focused on the diagnosis and management of infectious diseases. Its product is FebriDx, a point-of-care test for detecting and differentiating viral and bacterial respiratory infections. Its Service offering includes contract research and development services specialising in innovation, development, manufacturing and commercialisation of point-of-care diagnostic test solutions. The Company has one operating segment, being the provision of point-of-care diagnostics goods and services. It operates in the United States and Australia, with the majority of revenue generated from the United States.

  • Contact

    2724 Loker Avenue West
    CarlsbadCA92010
    USA

    T: +1 855 586-6739

    https://www.lumosdiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    Employees

Stocks News & Analysis

stocks

This Cheap ASX REIT may be overlooked

Takeover strengthens portfolio outlook for ASX REIT.
stocks

Do AI labs like Anthropic and OpenAI have economic moats?

Leading AI labs are building economic moats to stave off commodification threats.
stocks

12 picks for an income portfolio - Q3 2026 update

Passive income growth continues to be strong but two picks are facing challenges.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,937.0059.300.67%
CAC 407,812.148.810.11%
DAX 4025,213.35126.080.50%
Dow JONES (US)51,654.95423.310.83%
FTSE 10010,612.8860.830.58%
HKSE24,271.2059.850.25%
NASDAQ27,366.17172.830.64%
Nikkei 22569,030.9211.19-0.02%
NZX 50 Index13,827.6278.270.57%
S&P 5007,811.5446.180.59%
S&P/ASX 2008,783.2066.600.76%
SSE Composite Index3,797.2416.55-0.43%

Market Movers